Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940

Pozycja w akcjach #496
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Cena akcji
$1,028.49
Kapitalizacja rynkowa
$47.88B
Zmiana (1 dzień)
-3.67%
Zmiana (1 rok)
-18.37%
Kraj
KR
Handel Samsung Biologics Co.,Ltd. (207940)

Kategoria

Healthcare
Wskaźnik P/S dla Samsung Biologics Co.,Ltd. (207940)
Wskaźnik P/S na dzień October 2026 TTM: 14.48
Według najnowszych raportów finansowych i ceny akcji Samsung Biologics Co.,Ltd., obecny wskaźnik P/S (TTM) wynosi 14.48. Na koniec 2024 wynosił 19.31.
Historia wskaźnika P/S dla Samsung Biologics Co.,Ltd. od 2014 do 2026
Wskaźnik P/S na koniec każdego roku
Rok Wskaźnik P/S Zmień
2026 (TTM) 14.48 -15.84%
2025 17.20 -10.95%
2024 19.31 27.07%
2023 15.20 -20.91%
2022 19.22 -50.09%
2021 38.51 -18.79%
2020 47.42 14.90%
2019 41.27 -11.58%
2018 46.67 -16.73%
2017 56.06 83.95%
2016 30.47 -74.24%
2015 118.31 15.20%
2014 102.70 0.00%
Wskaźnik P/S dla podobnych firm lub konkurentów
Firma Wskaźnik P/S Różnica wskaźnika P/S Kraj
10.72 -25.93%
US
41.70 188.07%
US
4.19 -71.05%
AU
5.80 -59.96%
BE
10.44 -27.86%
NL